Methotrexate Generics - Manufacturers & Suppliers
Trexall®, Rheumatrex® (EU & US)
| Product/Composition:- | Methotrexate |
|---|---|
| Strength:- | Tablets: 2.5 mg, 5 mg, 10 mg, 15 mg; IV/IM: 25 mg/mL |
| Form:- | Oral tablets, Injection (IV and IM) |
| Reference Brands:- | Trexall®, Rheumatrex® (EU & US) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Methotrexate (brands Trexall®, Rheumatrex®) is a chemotherapy drug used to treat leukemia, lymphoma, breast cancer, and osteosarcoma. Available in oral tablets (2.5 mg to 15 mg) and injectable forms (25 mg/mL), Methotrexate is sourced by B2B pharma suppliers in the US and EU. It is GMP-compliant and widely used for both oncology treatments and autoimmune conditions, ensuring reliable supply and competitive pricing for hospitals and oncology centers.
Methotrexate, marketed under brand names like Trexall® and Rheumatrex®, is an essential chemotherapy drug and immunosuppressant used in the treatment of various oncologic conditions such as leukemia, lymphoma, breast cancer, and osteosarcoma. Available in oral and injectable forms, with strengths ranging from 2.5 mg to 25 mg/mL, Methotrexate is sourced globally by B2B pharmaceutical suppliers. It is GMP-compliant, ensuring consistent quality for hospitals and oncology centers. Methotrexate's wide availability in the US and EU supports effective cancer care at competitive pricing, making it a trusted option for treating aggressive cancers and autoimmune disorders.